Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.

Waterhouse JV, Holdich A, Mina F, Obeid M, Joshi K, Barrett S, Rajakumar L, McCormick G, Seymour S, Koliou P, Sylva R, Ayodele O, Gautam A, Smith J, McKeon J, Strawson-Smith T, Douglas R, Borley A, Konstantis A, McGrath S

Open source

DOI: 10.1016/j.clon.2025.103968
Published: 2026 Jan
Container: Clinical oncology (Royal College of Radiologists (Great Britain))
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clon.2025.103968,
  title = {Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.},
  author = {Waterhouse JV and Holdich A and Mina F and Obeid M and Joshi K and Barrett S and Rajakumar L and McCormick G and Seymour S and Koliou P and Sylva R and Ayodele O and Gautam A and Smith J and McKeon J and Strawson-Smith T and Douglas R and Borley A and Konstantis A and McGrath S},
  year = {2026},
  journal = {Clinical oncology (Royal College of Radiologists (Great Britain))},
  doi = {10.1016/j.clon.2025.103968},
  url = {https://doi.org/10.1016/j.clon.2025.103968}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.
AU  - Waterhouse JV
AU  - Holdich A
AU  - Mina F
AU  - Obeid M
AU  - Joshi K
AU  - Barrett S
AU  - Rajakumar L
AU  - McCormick G
AU  - Seymour S
AU  - Koliou P
AU  - Sylva R
AU  - Ayodele O
AU  - Gautam A
AU  - Smith J
AU  - McKeon J
AU  - Strawson-Smith T
AU  - Douglas R
AU  - Borley A
AU  - Konstantis A
AU  - McGrath S
PY  - 2026
JO  - Clinical oncology (Royal College of Radiologists (Great Britain))
DO  - 10.1016/j.clon.2025.103968
UR  - https://doi.org/10.1016/j.clon.2025.103968
ER  -

APA

JV, W., A, H., F, M., M, O., K, J., S, B., L, R., G, M., S, S., P, K., R, S., O, A., A, G., J, S., J, M., T, S., R, D., A, B., A, K., & S, M. (2026). Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.. Clinical oncology (Royal College of Radiologists (Great Britain)). https://doi.org/10.1016/j.clon.2025.103968

Source records

pubmed · retrieved 2026-09-26T09:20:24.195Z